VCYT — Veracyte Inc. stock price and chart

Share this page

VCYT

$43.12-2.86%

as of close, Oct 16, 2026

☾ AH $43.12 -2.86%

Veracyte Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.006%Russell 3000 0.006%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

10.020.030.040.050.060.070.080.0010.0M20.0M$43.12

2026-10-16

Price$43.12

MA20$46.94

MA50$40.74

Vol7.1M

What would $1,000 invested in VCYT be worth today? →

VCYT returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $43.12
YTD price return: +2.42%
YTD total return: +2.42%
Next earnings: Nov 3, 2026
Market cap: 3.5B2016-12 216.3M2026-10 3.5B+1503.5% over the window
Enterprise value: 3.2B
Shares outstanding: 80.4M2016-06 27.9M2026-06 80.4M+188.5% over the window
52W low: $29.46
52W high: $60.91
From 52W high: -29.21%
From 52W low: +46.39%
52W range: 43%

Volume

Rel volume: 1.46×
30D volume: 1.4M
30D $ vol: 61.5M

Fundamentals

Sales (ttm): 561.9M2016-06 54.6M2026-06 561.9M+929.1% over the window
Sales/share: $6.992016-06 $1.962026-06 $6.99+256.7% over the window
EPS (ttm): $1.412019-12 -$0.272026-06 $1.41-621.0% over the window
FCF (ttm): 166M2016-06 -31.8M2026-06 166M-621.3% over the window
FCF/share: $2.062016-06 -$1.142026-06 $2.06-280.7% over the window
Book value/share: $17.272016-06 $1.212026-06 $17.27+1325.8% over the window
Net margin: 20.37%2016-06 -70.1%2026-06 20.4%-129.1% over the window
ROE: 8.25%2016-06 -113.4%2026-06 8.2%-107.3% over the window
ROA: 7.70%2016-06 -51.1%2026-06 7.7%-115.1% over the window
Current ratio: 9.162016-06 4.002026-06 9.16+128.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +17.29%2025-06-30 → 2026-06-30479.1M → 561.9M (+17.3% total)+19.94%2023-03-31 → 2026-06-30311.2M → 561.9M (+80.6% total)+28.98%2021-06-30 → 2026-06-30157.5M → 561.9M (+256.8% total)+26.26%2016-06-30 → 2026-06-3054.6M → 561.9M (+929.1% total)
Net income: +335.16%2025-06-30 → 2026-06-3026.3M → 114.5M (+334.7% total)n/an/an/a
FCF: +97.78%2025-06-30 → 2026-06-3084M → 166M (+97.7% total)+163.23%2023-03-31 → 2026-06-307.1M → 166M (+2222.8% total)n/an/a
Shares: +2.19%2025-06-30 → 2026-06-3078.7M → 80.4M (+2.2% total)+3.27%2023-03-31 → 2026-06-3072.4M → 80.4M (+11.0% total)+3.57%2021-06-30 → 2026-06-3067.5M → 80.4M (+19.1% total)+11.18%2016-06-30 → 2026-06-3027.9M → 80.4M (+188.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +324.49%2025-06-30 → 2026-06-30$0.33 → $1.41 (+324.1% total)n/an/an/a
Sales/share: +14.78%2025-06-30 → 2026-06-30$6.09 → $6.99 (+14.8% total)+16.15%2023-03-31 → 2026-06-30$4.30 → $6.99 (+62.7% total)+24.54%2021-06-30 → 2026-06-30$2.33 → $6.99 (+199.5% total)+13.56%2016-06-30 → 2026-06-30$1.96 → $6.99 (+256.7% total)
FCF/share: +93.54%2025-06-30 → 2026-06-30$1.07 → $2.06 (+93.5% total)+154.90%2023-03-31 → 2026-06-30$0.10 → $2.06 (+1992.4% total)n/an/a
Book value/share: +11.28%2025-06-30 → 2026-06-30$15.52 → $17.27 (+11.3% total)+4.58%2023-03-31 → 2026-06-30$14.93 → $17.27 (+15.7% total)+3.71%2021-06-30 → 2026-06-30$14.39 → $17.27 (+20.0% total)+30.44%2016-06-30 → 2026-06-30$1.21 → $17.27 (+1325.8% total)
Price: +20.43%2025-10-16 → 2026-10-16$35.81 → $43.12 (+20.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+26.54%2023-10-16 → 2026-10-16$21.28 → $43.12 (+102.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.92%2021-10-15 → 2026-10-16$45.16 → $43.12 (-4.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+18.98%2016-10-14 → 2026-10-16$7.58 → $43.12 (+468.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +20.43%2025-10-16 → 2026-10-16$35.81 → $43.12 (+20.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+26.54%2023-10-16 → 2026-10-16$21.28 → $43.12 (+102.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.92%2021-10-15 → 2026-10-16$45.16 → $43.12 (-4.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+18.98%2016-10-14 → 2026-10-16$7.58 → $43.12 (+468.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 30.7×2016-12 -6.192026-10 30.30-589.8% over the window
Fwd P/E: 23.2×
P/S (ttm)Market cap ÷ TTM revenue.: 6.2×2016-12 3.552026-10 6.17+73.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.5×2016-12 7.212026-10 2.50-65.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 20.9×2016-12 -6.272026-10 20.90-433.6% over the window
EV/EBITDA (fy): 24.9×
EV/Sales (ttm): 5.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.79%2016-09 -16.0%2026-06 3.5%-122.0% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 80.4M ÷ 78.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -2.19%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.19%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -2.19%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($3.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($3.5B). Same caveat as the cash buyback yield.: 0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/S: 52nd
P/B: 40th
P/FCF: 7th

Bar = where today’s multiple sits in VCYT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.86%

-4.67%

+12.00%

-27.19%

YTD

+2.42%

+20.41%

-4.52%

Financial statements

Open full VCYT financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

VCYT — Veracyte Inc. price, chart and key statistics